Orient EuroPharma Co., Ltd. (TPEX:4120)
54.50
+2.10 (4.01%)
Feb 17, 2025, 9:00 AM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 4.75 billion as of February 21, 2025. Its market cap has increased by 42.71% in one year.
Market Cap
4.75B
Enterprise Value
8.84B
Revenue
4.47B
Ranking
n/a
PE Ratio
24.92
Stock Price
54.50
Market Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 4.75B, an increase of 578.32%. That is a compound annual growth rate of 9.88%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PharmaEssentia | 213.05B |
Caliway Biopharmaceuticals | 143.06B |
Bora Pharmaceuticals Co., LTD. | 90.22B |
Lotus Pharmaceutical | 72.97B |
Lumosa Therapeutics | 39.69B |
Oneness Biotech | 38.96B |
Polaris Group | 34.55B |
Pegavision | 30.65B |